Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 33
2003 36
2004 71
2005 58
2006 73
2007 62
2008 52
2009 78
2010 97
2011 89
2012 121
2013 121
2014 129
2015 114
2016 114
2017 81
2018 89
2019 135
2020 194
2021 247
2022 230
2023 242
2024 78

Text availability

Article attribute

Article type

Publication date

Search Results

2,249 results

Results by year

Filters applied: . Clear all
Page 1
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
Peffault de Latour R, Röth A, Kulasekararaj AG, Han B, Scheinberg P, Maciejewski JP, Ueda Y, de Castro CM, Di Bona E, Fu R, Zhang L, Griffin M, Langemeijer SMC, Panse J, Schrezenmeier H, Barcellini W, Mauad VAQ, Schafhausen P, Tavitian S, Beggiato E, Chew LP, Gaya A, Huang WH, Jang JH, Kitawaki T, Kutlar A, Notaro R, Pullarkat V, Schubert J, Terriou L, Uchiyama M, Wong Lee Lee L, Yap ES, Sicre de Fontbrune F, Marano L, Alashkar F, Gandhi S, Trikha R, Yang C, Liu H, Kelly RJ, Höchsmann B, Kerloeguen C, Banerjee P, Levitch R, Kumar R, Wang Z, Thorburn C, Maitra S, Li S, Verles A, Dahlke M, Risitano AM. Peffault de Latour R, et al. Among authors: kumar r. N Engl J Med. 2024 Mar 14;390(11):994-1008. doi: 10.1056/NEJMoa2308695. N Engl J Med. 2024. PMID: 38477987
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
Dagar G, Gupta A, Masoodi T, Nisar S, Merhi M, Hashem S, Chauhan R, Dagar M, Mirza S, Bagga P, Kumar R, Akil ASA, Macha MA, Haris M, Uddin S, Singh M, Bhat AA. Dagar G, et al. Among authors: kumar r. J Transl Med. 2023 Jul 7;21(1):449. doi: 10.1186/s12967-023-04292-3. J Transl Med. 2023. PMID: 37420216 Free PMC article. Review.
FAPI PET/CT Imaging-An Updated Review.
Chandekar KR, Prashanth A, Vinjamuri S, Kumar R. Chandekar KR, et al. Among authors: kumar r. Diagnostics (Basel). 2023 Jun 9;13(12):2018. doi: 10.3390/diagnostics13122018. Diagnostics (Basel). 2023. PMID: 37370912 Free PMC article. Review.
Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G, Kumar R, Yadav KK, Singh M, Pandita TK. Dagar G, et al. Among authors: kumar r. Biochim Biophys Acta Gene Regul Mech. 2023 Dec;1866(4):194979. doi: 10.1016/j.bbagrm.2023.194979. Epub 2023 Aug 24. Biochim Biophys Acta Gene Regul Mech. 2023. PMID: 37633647 Review.
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer.
Herbst RS, Majem M, Barlesi F, Carcereny E, Chu Q, Monnet I, Sanchez-Hernandez A, Dakhil S, Camidge DR, Winzer L, Soo-Hoo Y, Cooper ZA, Kumar R, Bothos J, Aggarwal C, Martinez-Marti A. Herbst RS, et al. Among authors: kumar r. J Clin Oncol. 2022 Oct 10;40(29):3383-3393. doi: 10.1200/JCO.22.00227. Epub 2022 Apr 22. J Clin Oncol. 2022. PMID: 35452273 Clinical Trial.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cascone T, Kar G, Spicer JD, García-Campelo R, Weder W, Daniel DB, Spigel DR, Hussein M, Mazieres J, Oliveira J, Yau EH, Spira AI, Anagnostou V, Mager R, Hamid O, Cheng LY, Zheng Y, Blando J, Tan TH, Surace M, Rodriguez-Canales J, Gopalakrishnan V, Sellman BR, Grenga I, Soo-Hoo Y, Kumar R, McGrath L, Forde PM. Cascone T, et al. Among authors: kumar r. Cancer Discov. 2023 Nov 1;13(11):2394-2411. doi: 10.1158/2159-8290.CD-23-0436. Cancer Discov. 2023. PMID: 37707791 Free PMC article. Clinical Trial.
Cisplatin-based combination therapy for cancer.
Minerva, Bhat A, Verma S, Chander G, Jamwal RS, Sharma B, Bhat A, Katyal T, Kumar R, Shah R. Minerva, et al. Among authors: kumar r. J Cancer Res Ther. 2023 Apr-Jun;19(3):530-536. doi: 10.4103/jcrt.jcrt_792_22. J Cancer Res Ther. 2023. PMID: 37470570 Free article. Review.
Prospects for developing allergen-depleted food crops.
Lokya V, Parmar S, Pandey AK, Sudini HK, Huai D, Ozias-Akins P, Foyer CH, Nwosu CV, Karpinska B, Baker A, Xu P, Liao B, Mir RR, Chen X, Guo B, Nguyen HT, Kumar R, Bera SK, Singam P, Kumar A, Varshney RK, Pandey MK. Lokya V, et al. Among authors: kumar r. Plant Genome. 2023 Dec;16(4):e20375. doi: 10.1002/tpg2.20375. Epub 2023 Aug 28. Plant Genome. 2023. PMID: 37641460 Free article. Review.
2,249 results